Literature DB >> 28027875

Bipolar cell reduction precedes retinal ganglion neuron loss in a complex 1 knockout mouse model.

Lanying Song1, Alfred Yu1, Karl Murray2, Gino Cortopassi3.   

Abstract

Inherited mitochondrial complex 1 deficiency causes Leber's hereditary Optic Neuropathy (LHON) and retinal ganglion cell (RGC) degeneration, and optic neuropathies are common in many inherited mitochondrial diseases. How mitochondrial defects pathomechanistically trigger optic neuropathy remains unclear. We observe that complex 1-deficient Ndufs4-/- mice present with acute vision loss around p30, and this vision loss is coincident with an 'inflammatory wave'. In order to understand what causes the inflammatory wave we explored retinal pathology that occurs from p20-p30. The results indicated that in the period p20-p30 in Ndufs4-/- retinas, there is: significant reduction in bipolar cells, RGC dendritic atrophy, reduced PSD95, increased oxidative stress as manifested by increased 4HNE, HO1 and Cuzn-SOD, increased mitochondrial biogenesis and increased apoptosis. These precede the major induction of 'inflammatory wave' at p30 shown previously, but occur earlier than frank RGC loss at p42. In general, complex 1 deficiency in retina triggers oxidative stress and mitochondrial respiratory dysfunction that causes death of the most sensitive cells, including bipolar cells and their synaptic contacts and amacrine cells in the early period, 20-24days. The early death of these cells is the likely precursor to the sharp rise in inflammatory molecules that occurs at day 30 and coincides with vision loss, and greatly precedes the death of RGCs that occurs at p42. These data suggest that metabolic antioxidant support of the most sensitive cells in the retina, or anti-inflammatory suppression of the consequences of their death, are both rational strategies for mitochondrial blinding disease.
Copyright © 2016. Published by Elsevier B.V.

Entities:  

Keywords:  Apoptosis; Mitochondrial complex I; Oxidase stress; Retinal bipolar cell; Retinal ganglion cell

Mesh:

Substances:

Year:  2016        PMID: 28027875     DOI: 10.1016/j.brainres.2016.12.019

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  12 in total

1.  Complex I mutations synergize to worsen the phenotypic expression of Leber's hereditary optic neuropathy.

Authors:  Yanchun Ji; Juanjuan Zhang; Yuanyuan Lu; Qiuzi Yi; Mengquan Chen; Shipeng Xie; Xiaoting Mao; Yun Xiao; Feilong Meng; Minglian Zhang; Rulai Yang; Min-Xin Guan
Journal:  J Biol Chem       Date:  2020-07-28       Impact factor: 5.157

2.  Rescue of cell death and inflammation of a mouse model of complex 1-mediated vision loss by repurposed drug molecules.

Authors:  Alfred K Yu; Sandipan Datta; Marissa Z McMackin; Gino A Cortopassi
Journal:  Hum Mol Genet       Date:  2017-12-15       Impact factor: 6.150

3.  Photoreceptors in a mouse model of Leigh syndrome are capable of normal light-evoked signaling.

Authors:  Sidney M Gospe; Amanda M Travis; Alexander V Kolesnikov; Mikael Klingeborn; Luyu Wang; Vladimir J Kefalov; Vadim Y Arshavsky
Journal:  J Biol Chem       Date:  2019-06-27       Impact factor: 5.157

4.  PRICKLE3 linked to ATPase biogenesis manifested Leber's hereditary optic neuropathy.

Authors:  Jialing Yu; Xiaoyang Liang; Yanchun Ji; Cheng Ai; Junxia Liu; Ling Zhu; Zhipeng Nie; Xiaofen Jin; Chenghui Wang; Juanjuan Zhang; Fuxin Zhao; Shuang Mei; Xiaoxu Zhao; Xiangtian Zhou; Minglian Zhang; Meng Wang; Taosheng Huang; Pingping Jiang; Min-Xin Guan
Journal:  J Clin Invest       Date:  2020-09-01       Impact factor: 14.808

Review 5.  Emerging model systems and treatment approaches for Leber's hereditary optic neuropathy: Challenges and opportunities.

Authors:  Tyler Bahr; Kyle Welburn; Jonathan Donnelly; Yidong Bai
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2020-02-24       Impact factor: 6.633

6.  Therapeutic effects of the mitochondrial ROS-redox modulator KH176 in a mammalian model of Leigh Disease.

Authors:  Ria de Haas; Devashish Das; Alejandro Garanto; Herma G Renkema; Rick Greupink; Petra van den Broek; Jeanne Pertijs; Rob W J Collin; Peter Willems; Julien Beyrath; Arend Heerschap; Frans G Russel; Jan A Smeitink
Journal:  Sci Rep       Date:  2017-09-15       Impact factor: 4.379

7.  miR-181a/b downregulation exerts a protective action on mitochondrial disease models.

Authors:  Alessia Indrieri; Sabrina Carrella; Alessia Romano; Alessandra Spaziano; Elena Marrocco; Erika Fernandez-Vizarra; Sara Barbato; Mariateresa Pizzo; Yulia Ezhova; Francesca M Golia; Ludovica Ciampi; Roberta Tammaro; Jorge Henao-Mejia; Adam Williams; Richard A Flavell; Elvira De Leonibus; Massimo Zeviani; Enrico M Surace; Sandro Banfi; Brunella Franco
Journal:  EMBO Mol Med       Date:  2019-05       Impact factor: 14.260

Review 8.  Ndufs4 knockout mouse models of Leigh syndrome: pathophysiology and intervention.

Authors:  Melissa A E van de Wal; Merel J W Adjobo-Hermans; Jaap Keijer; Tom J J Schirris; Judith R Homberg; Mariusz R Wieckowski; Sander Grefte; Evert M van Schothorst; Clara van Karnebeek; Albert Quintana; Werner J H Koopman
Journal:  Brain       Date:  2022-03-29       Impact factor: 13.501

Review 9.  Optic neuropathies: the tip of the neurodegeneration iceberg.

Authors:  Valerio Carelli; Chiara La Morgia; Fred N Ross-Cisneros; Alfredo A Sadun
Journal:  Hum Mol Genet       Date:  2017-10-01       Impact factor: 6.150

10.  Progressive optic atrophy in a retinal ganglion cell-specific mouse model of complex I deficiency.

Authors:  Luyu Wang; Mikael Klingeborn; Amanda M Travis; Ying Hao; Vadim Y Arshavsky; Sidney M Gospe
Journal:  Sci Rep       Date:  2020-10-01       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.